CFO Tribune: Week 40, 2026, Health and Life Sciences Dominate Activity

The week at a glance

SEC filings captured 21 CFO moves in the week of 2026-09-28 through 2026-10-04. The breakdown by event type was 6 departures, 6 transitions, 5 interims, and 4 appointments. Of the 15 seats filled, 7 came from internal promotions, 7 from external hires, and 1 could not be established. Interim arrangements made up 23.8% of all events. None of the incoming CFOs were identified as first-time CFOs; that status was not established for 7 of the incoming appointments.

Median tenure at departure could not be calculated because none of the 6 departures had known tenure on record.

Sector and company notes

Health and life sciences were the most active sectors. Biological Products (No Diagnostic Substances) led all sectors with 3 moves, and Pharmaceutical Preparations followed with 2. Across those categories, interim arrangements were prominent: Gain Therapeutics, Inc. named Gene Mack as interim CFO replacing Gianluca Fuggetta effective 2026-10-01, and Jasper Therapeutics, Inc. named Jeet Mahal as interim replacing Herb Cross effective 2026-10-09. Vir Biotechnology, Inc. completed a transition, with Aziz Sawaf, MBEE, MBA, CFA stepping in for Brent Sabatini, CPA, MBA effective 2026-10-05.

Among notable appointments, Levi Strauss & Co. named John Vandemore with an effective date of 2026-11-01, and Vestis Corporation appointed Russell Tiejema effective 2026-09-28.

In the Retail-Grocery Stores sector, Albertsons Companies, Inc. placed Cody Perdue in the interim CFO seat, replacing Sharon McCollam, effective 2026-09-30.

Several departures carry future effective dates. Northern Trust Corporation recorded the departure of David W. Fox, Jr. with an effective date of 2027-03-01, and Marathon Bancorp, Inc. recorded the departure of Joy C. Selting-Buchberger with an effective date of 2027-07-02. No incoming CFOs were named in either record. The sector label for 1 company in the week was not on the roster.